141 related articles for article (PubMed ID: 2456701)
1. Application of a T cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas.
Ng CS; Chan JK; Hui PK; Chan WC; Lo ST
Am J Pathol; 1988 Aug; 132(2):365-71. PubMed ID: 2456701
[TBL] [Abstract][Full Text] [Related]
2. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.
Gaulard P; Bourquelot P; Kanavaros P; Haioun C; Le Couedic JP; Divine M; Goossens M; Zafrani ES; Farcet JP; Reyes F
Am J Pathol; 1990 Sep; 137(3):617-28. PubMed ID: 1698028
[TBL] [Abstract][Full Text] [Related]
3. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
4. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
5. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
7. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level.
van Dongen JJ; Quertermous T; Bartram CR; Gold DP; Wolvers-Tettero IL; Comans-Bitter WM; Hooijkaas H; Adriaansen HJ; de Klein A; Raghavachar A
J Immunol; 1987 Feb; 138(4):1260-9. PubMed ID: 3100631
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
9. Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas.
Picker LJ; Brenner MB; Weiss LM; Smith SD; Warnke RA
Am J Pathol; 1987 Dec; 129(3):434-40. PubMed ID: 3501243
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.
Davey FR; Gatter KC; Ralfkiaer E; Pulford KA; Krissansen GW; Mason DY
Am J Pathol; 1987 Oct; 129(1):54-63. PubMed ID: 3310651
[TBL] [Abstract][Full Text] [Related]
11. Relationships among expression, transcription and rearrangement of T-cell receptor beta gene in T-cell lymphomas.
Kasai K; Kameya T; Ono M; Wada C; Kuwao S; Motoori T
Virchows Arch A Pathol Anat Histopathol; 1990; 417(1):57-65. PubMed ID: 2163138
[TBL] [Abstract][Full Text] [Related]
12. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
13. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
Dzembak TM; Gurkalo VK; Gershanovich ML
Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
[TBL] [Abstract][Full Text] [Related]
14. Rearrangement of T-cell receptor delta chain gene as a marker of lineage and clonality in T-cell lymphoproliferative disorders.
Kimura N; Takihara Y; Akiyoshi T; Yoshida T; Ohshima K; Kawara T; Hisano S; Kozuru M; Okumura M; Kikuchi M
Cancer Res; 1989 Aug; 49(16):4488-92. PubMed ID: 2501027
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of non-Hodgkin's lymphomas.
La Via MF; Self SE
Recenti Prog Med; 1990 Oct; 81(10):629-34. PubMed ID: 2291006
[TBL] [Abstract][Full Text] [Related]
16. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
Cartun RW; Coles FB; Pastuszak WT
Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic expression of non-Hodgkin's lymphomas in China.
Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
[TBL] [Abstract][Full Text] [Related]
18. [Biology and differentiation of lymphocytes in the classification of lymphomas].
Mariuzzi G; Di Loreto C; Mariuzzi L
Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
[TBL] [Abstract][Full Text] [Related]
19. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
